The president announced last week that his administration would be instituting a “most favored nation” policy that would peg ...

Learn more about how the Medicare Part D prescription payment structure changed in 2025 and how to maximize medication ...

President Donald Trump signed an Executive Order (EO) recently that will effectively place price controls on drugs that are ...

As part of a broader resurgence in pharmaceutical pricing reform and manufacturing policies in 2025, President Donald Trump ...

The Department of Health and Human Services today announced it has identified specific pricing targets for pharmaceutical ...

As of late 2024, only 14 state Medicaid programs cover GLP-1 drugs like Wegovy, Saxenda, or Zepbound for the treatment of obesity. These states are: California, Connecticut, Indiana, Maryland, ...

Tariffs on medications and raw ingredients impact global drug prices - hurting consumers and adding pressure to the healthcare system.

The inflated prices in the United States fuel global innovation while foreign health systems get a free ride.” ...

HHS is taking “immediate steps” to implement President Donald Trump’s executive order, Delivering Most-Favored-Nation Prescription Drug Pricing to American Patients — a key initiative aimed at ...

The Most Favored Nation order is unlikely to deliver broad, sustained savings without triggering legal challenges, ...

Shopping for the right hospital could save you money, according to the Michigan Health Purchasers Coalition (MIHPC). The group claims hospitals are ripping off patients ...

A study by the Rand Corp., a nonpartisan research organization, found that, across all drugs, U.S. prices were 2.78 times as ...